Request Free Sample
×
Industry Developments
Recent developments in the China Medical Device Second Opinion Market reflect a growing emphasis on advanced healthcare technologies and patient-centric solutions. In September 2023, Medtronic announced its collaboration with local Chinese healthcare providers to enhance telehealth services, aiming to streamline second opinions for complex medical procedures. Mindray has reported significant growth in market share, bolstered by innovative diagnostic devices that facilitate efficient consultations between patients and specialists. In October 2023, Siemens Healthineers launched a digital platform in China designed for remote second-opinion consultations, emphasizing accessibility and quality healthcare. Meanwhile, Boston Scientific has expanded its product portfolio in China, focusing on minimally invasive technologies that are increasingly being recommended through second opinions as healthcare providers seek the best outcomes for patients. Notably, October 2022 witnessed Johnson & Johnson's acquisition of a major Chinese medical device firm, enhancing its capabilities in the local market. Growth in key companies like GE Healthcare and Philips is also notable as they adapt to China's regulatory landscape, increasingly integrating AI to assist in the second opinion process. The market remains dynamic as firms respond to an evolving healthcare environment focused on quality and innovation.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 0.37(USD Billion) |
| MARKET SIZE 2024 | 0.42(USD Billion) |
| MARKET SIZE 2035 | 1.83(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 14.31% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Medtronic, Mindray, Philips, Boston Scientific, Johnson and Johnson, Siemens Healthineers, Hologic, Terumo, Canon Medical Systems, B.Braun, Fujifilm, GE Healthcare, Abbott Laboratories, Stryker, Olympus |
| SEGMENTS COVERED | Application Outlook, Source of Service Outlook, Services Outlook, Type Outlook |
| KEY MARKET OPPORTUNITIES | Telehealth integration, Rising chronic diseases, Increasing healthcare insurance, Advanced diagnostics technology, Growing demand for transparency |
| KEY MARKET DYNAMICS | growing healthcare expenditure, increasing telemedicine adoption, rising patient awareness, regulatory reforms, expanding elderly population |
| COUNTRIES COVERED | China |
Leave a Comment
FAQs
What is the expected market size of the China Medical Device Second Opinion Market in 2024?
The China Medical Device Second Opinion Market is expected to be valued at 0.42 USD Billion in 2024.
What market value is projected for the China Medical Device Second Opinion Market by 2035?
By 2035, the market is projected to reach a value of 1.83 USD Billion.
What is the expected compound annual growth rate (CAGR) for the market from 2025 to 2035?
The expected CAGR for the China Medical Device Second Opinion Market from 2025 to 2035 is 14.31%.
Which application is forecasted to have the highest market value in 2035?
The Cancer segment is forecasted to have the highest market value of 0.52 USD Billion in 2035.
What is the anticipated market value for the Diabetes segment in 2024?
The Diabetes segment is anticipated to be valued at 0.09 USD Billion in 2024.
Who are the key players in the China Medical Device Second Opinion Market?
Key players in the market include Medtronic, Mindray, Philips, and Boston Scientific among others.
What will be the market value of the Cardiac Disorders segment by 2035?
The market value for the Cardiac Disorders segment is expected to reach 0.42 USD Billion by 2035.
How much is the market for Neurological Disorders expected to grow by 2035?
The market for Neurological Disorders is expected to grow to 0.27 USD Billion by 2035.
What is the projected market value for Respiratory Disorders in 2024?
In 2024, the projected market value for Respiratory Disorders is 0.05 USD Billion.
What is a significant growth driver for the China Medical Device Second Opinion Market?
The increasing prevalence of chronic diseases is a significant growth driver for the market.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense